CDC director breaks with agency advisers to endorse Pfizer booster for at-risk workers
“It is my job to recognize where our actions can have the greatest impact,” Rochelle Walensky said.
Today's Liberal News
By Lauren Morello
CDC director breaks with agency advisers to endorse Pfizer booster for at-risk workers
“It is my job to recognize where our actions can have the greatest impact,” Rochelle Walensky said.
CDC director breaks with agency advisers to endorse Pfizer booster for at-risk workers
“It is my job to recognize where our actions can have the greatest impact,” Rochelle Walensky said.
Johnson & Johnson says booster shot provides strong protection against Covid-19
The booster data has not yet been peer-reviewed or published in a scientific journal.
J&J says second-dose study supports use of booster shots
The findings come as the Biden administration is firming up plans to roll out booster shots to adults in late September.
J&J says second-dose study supports use of booster shots
The findings come as the Biden administration is firming up plans to roll out booster shots to adults in late September.
J&J says second-dose study supports use of booster shots
The findings come as the Biden administration is firming up plans to roll out booster shots to adults in late September.
J&J says second-dose study supports use of booster shots
The findings come as the Biden administration is firming up plans to roll out booster shots to adults in late September.
Moderna seeks full FDA approval of its Covid-19 vaccine
The company is the second vaccine maker to seek full approval from U.S. regulators.
Moderna seeks full FDA approval of its Covid-19 vaccine
The company is the second vaccine maker to seek full approval from U.S. regulators.
Feds recommend pausing J&J vaccine over blood clotting concerns
The pause comes after six women between the ages of 18 and 48 developed severe blood clots days after receiving the single-shot vaccine.
Feds recommend pausing J&J vaccine over blood clotting concerns
The pause comes after six women between the ages of 18 and 48 developed severe blood clots days after receiving the single-shot vaccine.
FDA authorizes first Covid-19 vaccine for emergency use
The Pfizer vaccine proved 95 percent effective in a massive clinical trial.
FDA authorizes first Covid-19 vaccine for emergency use
The Pfizer vaccine proved 95 percent effective in a massive clinical trial.
What we know — and don’t — about Pfizer’s promising vaccine results
The better-than-expected result is the first Phase III data from any of the four candidates now in the final stage of testing in the U.S.
What we know — and don’t — about Pfizer’s promising vaccine results
The better-than-expected result is the first Phase III data from any of the four candidates now in the final stage of testing in the U.S.